Human Plasma-Derived Therapeutics Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281346 No. of Pages: 60 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Human Plasma-Derived Therapeutics in Global, including the following market information:
Global Human Plasma-Derived Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Plasma-Derived Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Albumin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Plasma-Derived Therapeutics include Alkahest, Baxter, CSL Behring, Entegrion, Inc., Gammagard, Grifols, Kedrion, Octapharma and Prometic Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Plasma-Derived Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Plasma-Derived Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Plasma-Derived Therapeutics Market Segment Percentages, by Type, 2021 (%)
Albumin
Immunoglobulin
Clotting Factor
Prothrombin Complex
Others
Global Human Plasma-Derived Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Plasma-Derived Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Research Center
Global Human Plasma-Derived Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Plasma-Derived Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Plasma-Derived Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Plasma-Derived Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkahest
Baxter
CSL Behring
Entegrion, Inc.
Gammagard
Grifols
Kedrion
Octapharma
Prometic Life Sciences
Sanquin
Takeda
1 Introduction to Research & Analysis Reports
1.1 Human Plasma-Derived Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Plasma-Derived Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Plasma-Derived Therapeutics Overall Market Size
2.1 Global Human Plasma-Derived Therapeutics Market Size: 2021 VS 2028
2.2 Global Human Plasma-Derived Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Plasma-Derived Therapeutics Players in Global Market
3.2 Top Global Human Plasma-Derived Therapeutics Companies Ranked by Revenue
3.3 Global Human Plasma-Derived Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Human Plasma-Derived Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Plasma-Derived Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Plasma-Derived Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Human Plasma-Derived Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Plasma-Derived Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Human Plasma-Derived Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Albumin
4.1.3 Immunoglobulin
4.1.4 Clotting Factor
4.1.5 Prothrombin Complex
4.1.6 Others
4.2 By Type - Global Human Plasma-Derived Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Human Plasma-Derived Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Human Plasma-Derived Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Human Plasma-Derived Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Plasma-Derived Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.2 By Application - Global Human Plasma-Derived Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Human Plasma-Derived Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Human Plasma-Derived Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Human Plasma-Derived Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Human Plasma-Derived Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Human Plasma-Derived Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Human Plasma-Derived Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Human Plasma-Derived Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Human Plasma-Derived Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Human Plasma-Derived Therapeutics Revenue, 2017-2028
6.3.2 US Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.3.3 Canada Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.3.4 Mexico Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Human Plasma-Derived Therapeutics Revenue, 2017-2028
6.4.2 Germany Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4.3 France Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4.4 U.K. Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4.5 Italy Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4.6 Russia Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.4.8 Benelux Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Human Plasma-Derived Therapeutics Revenue, 2017-2028
6.5.2 China Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.5.3 Japan Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.5.4 South Korea Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.5.6 India Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Human Plasma-Derived Therapeutics Revenue, 2017-2028
6.6.2 Brazil Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.6.3 Argentina Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Plasma-Derived Therapeutics Revenue, 2017-2028
6.7.2 Turkey Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.7.3 Israel Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Human Plasma-Derived Therapeutics Market Size, 2017-2028
6.7.5 UAE Human Plasma-Derived Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Alkahest
7.1.1 Alkahest Corporate Summary
7.1.2 Alkahest Business Overview
7.1.3 Alkahest Human Plasma-Derived Therapeutics Major Product Offerings
7.1.4 Alkahest Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Alkahest Key News
7.2 Baxter
7.2.1 Baxter Corporate Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Human Plasma-Derived Therapeutics Major Product Offerings
7.2.4 Baxter Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Baxter Key News
7.3 CSL Behring
7.3.1 CSL Behring Corporate Summary
7.3.2 CSL Behring Business Overview
7.3.3 CSL Behring Human Plasma-Derived Therapeutics Major Product Offerings
7.3.4 CSL Behring Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.3.5 CSL Behring Key News
7.4 Entegrion, Inc.
7.4.1 Entegrion, Inc. Corporate Summary
7.4.2 Entegrion, Inc. Business Overview
7.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Major Product Offerings
7.4.4 Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Entegrion, Inc. Key News
7.5 Gammagard
7.5.1 Gammagard Corporate Summary
7.5.2 Gammagard Business Overview
7.5.3 Gammagard Human Plasma-Derived Therapeutics Major Product Offerings
7.5.4 Gammagard Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Gammagard Key News
7.6 Grifols
7.6.1 Grifols Corporate Summary
7.6.2 Grifols Business Overview
7.6.3 Grifols Human Plasma-Derived Therapeutics Major Product Offerings
7.6.4 Grifols Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Grifols Key News
7.7 Kedrion
7.7.1 Kedrion Corporate Summary
7.7.2 Kedrion Business Overview
7.7.3 Kedrion Human Plasma-Derived Therapeutics Major Product Offerings
7.7.4 Kedrion Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Kedrion Key News
7.8 Octapharma
7.8.1 Octapharma Corporate Summary
7.8.2 Octapharma Business Overview
7.8.3 Octapharma Human Plasma-Derived Therapeutics Major Product Offerings
7.8.4 Octapharma Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Octapharma Key News
7.9 Prometic Life Sciences
7.9.1 Prometic Life Sciences Corporate Summary
7.9.2 Prometic Life Sciences Business Overview
7.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Major Product Offerings
7.9.4 Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Prometic Life Sciences Key News
7.10 Sanquin
7.10.1 Sanquin Corporate Summary
7.10.2 Sanquin Business Overview
7.10.3 Sanquin Human Plasma-Derived Therapeutics Major Product Offerings
7.10.4 Sanquin Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Sanquin Key News
7.11 Takeda
7.11.1 Takeda Corporate Summary
7.11.2 Takeda Business Overview
7.11.3 Takeda Human Plasma-Derived Therapeutics Major Product Offerings
7.11.4 Takeda Human Plasma-Derived Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Takeda Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com